-- with Jasvir Singh
Writer
James Ottar Grundvig, who has an autistic child, spoke with Hollander about his
past research, in which he showed that oxytocin could improve some of the
symptoms of autism spectrum disorder, as well as what he plans for the future.
Hollander recently moved from the Seaver and New York Autism Center of
Excellence at Mt. Sinai School of Medicine to the Child Psychiatry Annex at the
Montefiore Medical Center University Hospital for Albert Einstein College of
Medicine.
The
interview recaps Hollander's ground-breaking studies showing that intravenous
or intranasal oxytocin improved
emotions, strengthened trust bonds, and reduced or eliminated repetitive
behavior in healthy adults with ASD -- with improvement lasting two weeks after
a single dose.
Hollander
also comments on other studies showing that oxytocin may help with schizophrenia and social anxiety disorder.
Dr. Hollander is a
clinical psychiatrist who spearheaded autism research at Mount Sinai School of
Medicine and chairs the Advisory Board of icare4autism. He believes that doing oxytocin studies on ASD
(Autism Spectrum Disorder) children is over two years away. More evidence and
safety needs to be obtained before the FDA approves that phase of research.
Until then, studies will focus on young adults, according to the interview.
You can
read the entire interview here in the Epoch Times.
